Literature DB >> 23588367

Cytoplasmic staining of OCT4 is a highly sensitive marker of adrenal medullary-derived tissue.

Riley E Alexander1, Liang Cheng, David J Grignon, Muhammad Idrees.   

Abstract

OCT4 immunostaining has become an essential resource in diagnosing germ cell neoplasia. OCT4 is a transcription factor with a characteristic nuclear staining pattern specific to germ cell neoplasms. Our institution has observed that paraganglionic tissue consistently displayed intense cytoplasmic staining by utilizing monoclonal OCT4 antibody, and we intended to determine whether OCT4 could provide additional diagnostic utility in adrenal tumors. We used monoclonal and polyclonal OCT4 antibodies for comparison of staining patterns and intensities. Thirty-eight pheochromocytomas (8 metastatic), 22 adrenal cortical carcinomas (2 metastatic), 15 metastatic tumors to the adrenal glands, and 10 normal adrenal glands containing cortical and medullary tissue were immunostained with OCT4. A 4-tier system (0 to 3), for recording intensity and extent of cytoplasmic staining, was used. All 30 primary pheochromocytomas displayed strong and diffuse (3+3) cytoplasmic immunoexpression. Six of 8 metastatic pheochromocytomas showed strong immunoexpression (3+3), whereas the remaining 2 showed moderate intensity (2+3). All 22 adrenal cortical carcinomas, including metastatic cases, were completely negative. Only 2 metastatic tumors to the adrenal gland showed weak, cytoplasmic positivity: a small cell carcinoma and a Merkel cell carcinoma. Controls stained in an appropriate nuclear manner. Immunoelectron microscopy demonstrated the antibody interacting with neurosecretory granules. To our knowledge, the cytoplasmic expression of OCT4 in adrenal medulla and pheochromocytoma has not been specifically studied. The goal of this study is to analyze the immunoreactivity of adrenal cortical carcinoma and pheochromocytoma to OCT4 and determine the sensitivity and specificity of this particular staining pattern and to compare monoclonal and polyclonal antibodies.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23588367     DOI: 10.1097/PAS.0b013e3182793dc2

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  4 in total

1.  Unique trophoblast stem cell- and pluripotency marker staining patterns depending on gestational age and placenta-associated pregnancy complications.

Authors:  Maja Weber; Claudia Göhner; Sebastian San Martin; Aurelia Vattai; Stefan Hutter; Mario Parraga; Udo Jeschke; Ekkehard Schleussner; Udo R Markert; Justine S Fitzgerald
Journal:  Cell Adh Migr       Date:  2016-02-25       Impact factor: 3.405

2.  Oct4B, CD90, and CD73 are upregulated in bladder tissue following electro-resection of the bladder.

Authors:  Takumi Takeuchi; Akiko Tonooka; Yumiko Okuno; Mami Hattori-Kato; Koji Mikami
Journal:  J Stem Cells Regen Med       Date:  2016-05-30

3.  From ACTH-Dependent to ACTH-Independent Cushing's Syndrome from a Malignant Mixed Corticomedullary Adrenal Tumor: Potential Role of Embryonic Stem Cells.

Authors:  Claudia Ramírez-Rentería; Ana Laura Espinosa-De-Los-Monteros; Espinosa-Cardenas Etual; Daniel Marrero-Rodríguez; Guillermo Castellanos; Rocio Arreola-Rosales; Guillermo Montoya-Martinez; Keiko Taniguchi-Ponciano; Paola Briseño-Díaz; Mayte Lizeth Padilla-Cristerna; María Del Pilar Figueroa-Corona; Mercado Moises
Journal:  Case Rep Endocrinol       Date:  2020-05-04

Review 4.  Cancer Stem Cells in Pheochromocytoma and Paraganglioma.

Authors:  Laura D Scriba; Stefan R Bornstein; Alice Santambrogio; Gregor Mueller; Angela Huebner; Julia Hauer; Andreas Schedl; Ben Wielockx; Graeme Eisenhofer; Cynthia L Andoniadou; Charlotte Steenblock
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-25       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.